Your browser doesn't support javascript.
loading
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.
Luber, Raphael P; O'Neill, Rhona; Singh, Sukhpreet; Sharma, Esha; Cunningham, Georgina; Honap, Sailish; Meade, Susanna; Ray, Shuvra; Anderson, Simon H; Mawdsley, Joel; Sanderson, Jeremy D; Samaan, Mark A; Arkir, Zehra; Irving, Peter M.
Afiliação
  • Luber RP; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • O'Neill R; Department of Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Singh S; Department of Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Sharma E; Department of Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Cunningham G; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Honap S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Meade S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Ray S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Anderson SH; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Mawdsley J; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Sanderson JD; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Samaan MA; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Arkir Z; Viapath Analytics, Guy's & St Thomas' NHS Foundation Trust, London, UK.
  • Irving PM; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Aliment Pharmacol Ther ; 54(5): 678-688, 2021 09.
Article em En | MEDLINE | ID: mdl-34223654

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Doenças Inflamatórias Intestinais / Medicamentos Biossimilares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Aliment Pharmacol Ther Assunto da revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Doenças Inflamatórias Intestinais / Medicamentos Biossimilares Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Aliment Pharmacol Ther Assunto da revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido